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patients (but we did observe lesions on 
the necks of some patients).
Our data coincided with those 
of the French study and reinforce the 
specifi city of this dermatologic sign. 
However, this was not the only coin-
cidence; cases also occurred among 
the investigators after contact with the 
infected material in each of the out-
breaks. Perhaps both signs may char-
acteristic this dermatitis: the comet 
sign and “the sign of the infected in-
vestigators” of the outbreaks.
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Helicobacter 
pylori Infection in 
Patients Undergoing 
Upper Endoscopy, 
Republic of Georgia
To the Editor: Helicobacter py-
lori infection is the principal cause 
of chronic active gastritis and peptic 
ulcer disease and a major contributor 
for gastric adenocarcinoma and mu-
cosa-associated lymphoid tissue lym-
phoma (1). Approximately 50% of the 
world’s population is infected (2), but 
only 10%–20% of infected persons 
become symptomatic (3). The annual 
incidence rate of H. pylori infection 
is ≈4%–15% in developing countries, 
compared with ≈0.5% in industrialized 
countries (4). Studies in the Republic 
of Georgia (ROG), a developing coun-
try with an economy in transition, 
suggested that >70% of adults are in-
fected with H. pylori (5,6) and that the 
prevalence rate of gastric cancer is 18 
cases per 100,000 population, ≈6- to 
9-fold higher than in the United States 
(National Center for Disease Control, 
Tbilisi, ROG, unpub. data, 2003). We 
investigated the prevalence of infec-
tion in patients in ROG in whom gas-
tritis, peptic ulcer, and gastric cancer 
had been diagnosed.
We performed a cross-sectional 
study of patients referred for upper 
endoscopy from all regions of ROG 
to 23 tertiary-care medical centers in 
the capital, Tbilisi, during 2003–2005. 
Patients whose medical records and 
gastric biopsy slides were available 
were eligible for inclusion. Two pa-
thologists reviewed hematoxylin and 
eosin–stained slides prepared from 
formalin-fi xed, paraffi n-embedded 
gastric biopsy specimens. Pathologists 
graded the amounts of H. pylori, acute 
and chronic infl ammation, intestinal 
metaplasia, and atrophy according to 
the visual analogue scale of the Up-
dated Sydney Classifi cation System 
for Gastritis (7). Histologic character-
istics were dichotomized as presence 
(grades >1) or absence (grade = 0) of 
a feature.
We conducted statistical analyses 
in SAS version 9.0 (SAS Institute, Inc., 
Cary, NC, USA). The human subjects 
committees at the National Center for 
Disease Control and Medical Statistics 
of ROG and the Centers for Disease 
Control and Prevention (Atlanta, GA, 
USA) approved the study.
We identifi ed 90 eligible persons. 
Their median age was 62 years (range 
6–81 years); 48 (54%) were male. Bi-
opsy specimens were taken from the 
antrum in 89 (99%) persons and from 
the corpus in 1 person. H. pylori infec-
tion was diagnosed in 59 (72%) per-
sons, acute infl ammation in 81 (90%), 
chronic infl ammation in 77 (87%), 
metaplasia in 29 (35%), and atrophy 
in 11 (16%). H. pylori was detected in 
78% of patients who had gastritis, in 
58% of patients who had peptic ulcer, 
and in 58% of patients who had dys-
plasia or gastric cancer (Table).
In a multivariable Poisson re-
gression model, H. pylori positivity 
was strongly associated with acute in-
fl ammation (adjusted prevalence ratio 
[aPR] 1.4, 95% confi dence interval 
[CI] 1.2–1.8) and chronic infl amma-
tion (aPR 1.5, 95% CI 1.2–1.9). Age 
>50 years (aPR 0.9, 95% CI 0.8–1.2) 
and male sex (aPR 1.0, 95% CI 0.9–
1.2) did not confer increased risk for 
H. pylori infection.
H. pylori requires gastric mucus 
for growth, and mucus produced by 
the metaplastic and neoplastic cells is 
postulated to lack characteristics that 
sustain growth of H. pylori. When H. 
pylori has been observed in patients 
with ulcers, intestinal metaplasia, and 
adenocarcinoma, the bacteria usually 
are present in areas of the stomach that 
do not have these lesions.
In this cohort of patients, 14 (16%) 
had dysplasia or adenocarcinoma. 
Dysplasia and eventually cancer occur 
in a small group of susceptible persons 
with atrophy and intestinal metaplasia 
(8,9). Thus, H. pylori is now consid-
ered a type-1 carcinogen, and the ab-
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sence of infection is predicted to result 
in at least 60% fewer cases of gastric 
cancer worldwide (10).
Our study has several limitations. 
First, because of the study’s retrospec-
tive nature, pathologists reviewed ar-
chived hematoxylin and eosin–stained 
sections of biopsy specimens. The 
inability to use additional techniques 
(e.g., special staining, immunohis-
tochemistry) commonly used to visu-
alize H. pylori might have resulted in 
underdetection of the true rate of infec-
tion in the study population. Second, in 
99% of cases, only 1 biopsy specimen 
was obtained from the antrum instead 
of the 5 antrum and corpus biopsy 
specimens recommended for appropri-
ate diagnosis by the Updated Sydney 
Classifi cation System (7). Third, the 
relatively small sample size precluded 
exploration of additional relationships 
between demographic characteristics 
and histologic grades.
Our results indicate a high preva-
lence of H. pylori in patients with gas-
tritis, peptic ulcer, and gastric cancer 
and suggest that H. pylori infection 
represents a serious public health 
problem in ROG. Studies are needed 
to explore demographic, socioeco-
nomic, and behavioral risk factors that 
contribute to the high prevalence of H. 
pylori infection in symptomatic and 
asymptomatic persons living in ROG 
so that preventive measures can be 
identifi ed.
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Table. Histopathologic characteristics assessed in the biopsy specimens of study participants, by final pathologic diagnosis, Republic
of Georgia, 2003–2005 
Final pathologic diagnosis 
No. Heliobacter
pylori positive/no. 
tested (%), n = 82
No. with acute 
inflammation/no.
tested (%), n = 90 
No. with chronic 
inflammation/no.
tested (%), n = 89
No. with intestinal 
metaplasia/no.
tested (%), n = 84 
No. with glandular 
atrophy/no. tested 
(%), n = 68 
Gastritis* (n = 62) 45/58 (78) 55/62 (89) 55/62 (89) 19/60 (32) 10/50 (20) 
Peptic ulcer (n = 14) 7/12 (58) 14/14 (100) 12/13 (92) 5/13 (38) 1/10 (10) 
Dysplasia or cancer (n = 14) 7/12 (58) 12/14 (86) 10/14 (71) 5/11 (45) 0/8 (0) 
Total (n = 90) 59/82 (72) 81/90 (90) 77/89 (87) 29/84 (35) 11/68 (16) 
*According to the Updated Sydney Classification System for Gastritis (7). 
